Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
Frontiers in Oncology · 15.06.2023 · 13
DOI: 10.3389/fonc.2023.1174252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 15.06.2023. Verfasst von Meng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Backgrounds Bladder cancer (BLCA) is one of the most prevalent cancers of the genitourinary system, the clinical outcomes of patients with BLCA are bad, and the morbidity rate is high. One of the key components of the tumor microenvironment (TME) is cancer-associated fibroblasts (CAFs) which are critically involved in BLCA tumorigenesis. Previous studies have shown the involvement of CAFs in tumor growth, cancer progression, immune evasion, angiogenesis, and chemoresistance in several cancers such as breast, colon, pancreatic, ovarian, and prostate cancers. However, only a few studies have shown the role of CAFs in the occurrence and development of BLCA.
Methods
We have retrieved and merged the data on RNA-sequencing of patients with BLCA from databases including “the Cancer Genome Atlas” and “Gene Expression Omnibus.” Next, we compared the differences in CAFs-related genes (CRGs) expression between normal and BLCA tissues. Based on CRGs expression, we randomly divided patients into two groups. Next, we determined the correlation between CAFs subtypes and differentially expressed CRGs (DECRGs) between the two subtypes. Furthermore, the “Gene Ontology” and “Kyoto Encyclopedia of Genes and Genomes pathway” enrichment analyses were conducted to determine the functional characteristics between the DECRGs and clinicopathology.
Results
We identified five genes ( POF1B, ARMCX1, ALDOC, C19orf33 , and KRT13 ) using multivariate COX regression and “Least Absolute Shrinkage and Selection Operator (LASSO) COX regression analysis” for developing a prognostic model and calculating the CRGs-risk score. The TME, mutation, CSC index, and drug sensitivity were also analyzed.
Conclusion
We constructed a novel five- CRGs prognostic model, which sheds light on the roles of CAFs in BLCA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Urology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Zitieren
APA
Zhang, M., Zhu, J., Zhang, P., Li, L., Min, M., Li, T., & He, W. (2023). Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1174252
Vancouver
Zhang M, Zhu J, Zhang P, Li L, Min M, Li T, et al. Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1174252
BibTeX
@article{Zhang2023,
author = {Zhang, Meng and Zhu, Junlong and Zhang, Pan and Li, Lingxun and Min, Min and Li, Tinghao and He, Weiyang},
title = {Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1174252}
}
EUVIMED